EP
Eversept Partners’s Sarepta Therapeutics SRPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-138,644
| Closed | -$23.6M | – | 88 |
|
2020
Q4 | $23.6M | Buy |
138,644
+136,747
| +7,209% | +$23.3M | 2.77% | 15 |
|
2020
Q3 | $266K | Sell |
1,897
-69,834
| -97% | -$9.81M | 0.06% | 45 |
|
2020
Q2 | $11.5M | Buy |
+71,731
| New | +$11.5M | 1.58% | 18 |
|
2020
Q1 | – | Sell |
-75,000
| Closed | -$9.68M | – | 74 |
|
2019
Q4 | $9.68M | Buy |
+75,000
| New | +$9.68M | 1.71% | 15 |
|
2019
Q3 | – | Sell |
-16,554
| Closed | -$2.52M | – | 61 |
|
2019
Q2 | $2.52M | Sell |
16,554
-67,020
| -80% | -$10.2M | 0.7% | 31 |
|
2019
Q1 | $9.96M | Buy |
83,574
+43,080
| +106% | +$5.13M | 2.91% | 11 |
|
2018
Q4 | $4.42M | Sell |
40,494
-1,700
| -4% | -$186K | 2.39% | 11 |
|
2018
Q3 | $6.81M | Buy |
42,194
+2,194
| +5% | +$354K | 2.99% | 11 |
|
2018
Q2 | $5.29M | Buy |
+40,000
| New | +$5.29M | 2.42% | 15 |
|